Dr. Siddaramana Gowda joined Amrita Institute of medical sciences on 2012 december as lecturer. He is a postgraduate in Physics from Pondichery Central University and completed his doctoral degree in Nanomaterial science on Synthesis and characterisation of multifunctional nanoparticles from DRDO (JNVU Jodhpur).

He adds to hid credit 9 peer reviewed journal articles in various prestigious journals like Biomaterials, International journal of green nanotechnology, Journal of luminescence etc.

Presently he is working on multifunctional nanoparticles optical and magnetic resonance imaging applications.


Publication Type: Journal Article

Year of Publication Publication Type Title


Journal Article

R. Ramachandran, Junnuthula, V. Reddy, Gowd, S., Ashokan, A., Thomas, J., Peethambaran, R., Thomas, A., Unni, A. Kodakara K., Panikar, D., Shantikumar V Nair, and Dr. Manzoor K., “Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma.”, Sci Rep, vol. 7, p. 43271, 2017.[Abstract]

Localized and controlled delivery of chemotherapeutics directly in brain-tumor for prolonged periods may radically improve the prognosis of recurrent glioblastoma. Here, we report a unique method of nanofiber by fiber controlled delivery of anti-cancer drug, Temozolomide, in orthotopic brain-tumor for one month using flexible polymeric nano-implant. A library of drug loaded (20 wt%) electrospun nanofiber of PLGA-PLA-PCL blends with distinct in vivo brain-release kinetics (hours to months) were numerically selected and a single nano-implant was formed by co-electrospinning of nano-fiber such that different set of fibres releases the drug for a specific periods from days to months by fiber-by-fiber switching. Orthotopic rat glioma implanted wafers showed constant drug release (116.6 μg/day) with negligible leakage into the peripheral blood (<100 ng) rendering ~1000 fold differential drug dosage in tumor versus peripheral blood. Most importantly, implant with one month release profile resulted in long-term (>4 month) survival of 85.7% animals whereas 07 day releasing implant showed tumor recurrence in 54.6% animals, rendering a median survival of only 74 days. In effect, we show that highly controlled drug delivery is possible for prolonged periods in orthotopic brain-tumor using combinatorial nanofibre libraries of bulk-eroding polymers, thereby controlling glioma recurrence.

More »»
PDF icon theranostic-3-dimensional-nano-brain-implant-for-prolonged-and-localized-treatment-of-recurrent-glioma.pdf


Journal Article

V. H. Somasundaram, Pillai, R., Malarvizhi, G., Ashokan, A., Gowd, S., Peethambaran, R., Palaniswamy, S., Unni, A. K. K., Nair, S., and Dr. Manzoor K., “Biodegradable Radiofrequency Responsive Nanoparticles for Augmented Thermal Ablation Combined with Triggered Drug Release in Liver Tumors”, ACS Biomaterials Science and Engineering, vol. 2, pp. 768-779, 2016.[Abstract]

Radiofrequency ablation (RFA) and doxorubicin (Dox) chemotherapy are separately approved for liver cancer therapy; however, both have limited success in the clinic due to suboptimal/nonuniform heating and systemic side effects, respectively. Here, we report a biodegradable nanoparticle (NP) system showing excellent RF hyperthermic response together with the ability to locally deliver Dox in the liver under RF trigger and control. The nanosystem was prepared by doping a clinically permissible dose (∼4.3 wt %, 0.03 ppm) of stannous ions in alginate nanoparticles (∼100 nm) coloaded with Dox at ∼13.4 wt % concentration and surface conjugated with galactose for targeting asialo-glycoprotein receptors in liver tumors. Targeted NP-uptake and increased cytotoxicity when combined with RF exposure was demonstrated in HEPG2 liver cancer cells. Following in vitro (chicken liver phantom) demonstration of locally augmented RF thermal response, in vivo scintigraphic imaging of 99Tc-labeled NPs was performed to optimize liver localization in Sprague-Dawley (SD) rats. RF ablation was performed in vivo using a cooled-tip probe, and uniformly enhanced (∼44%) thermal ablation was demonstrated with magnetic resonance imaging along with RF-controlled Dox release. In orthotopic rat liver tumor models, real-time infrared imaging revealed significantly higher (∼20 °C) RF thermal response at the tumor site, resulting in uniform augmented ablation (∼80%) even at a low RF power exposure of 15 W for just 1 min duration. Being a clinically acceptable, biodegradable material, alginate nanoparticles hold strong translational potential for augmented RF hyperthermia combined with triggered drug release.

More »»

NIRF 2017